Zum Inhalt springen

Digital Therapeutics (DTx) | Digital Health Applications (DiGA)

Your Beyond the Pill app in 8 weeks

The mHealth Suite infrastructure platform has established a new standard for digital therapy products that greatly optimizes time to market and cost efficiency. For the specific needs of orphan drug manufacturers, this opens up new perspectives for a direct channel into the patient community.

Our solution for orphan drug providers

The mHealth Suite addresses the following challenges

Missing channel to the patient community

Connecting with people affected by a rare disease can be challenging. Health apps can serve as a platform for patient communities and create great added value as a support network among patients. The provider of a corresponding app can strengthen a positive perception through this offer.

Advertising restriction before drug approval

One of the biggest challenges with drugs for orphan diseases is the lengthy approval process. With a digital offering Beyond the Pill, companies can establish a market presence at an early stage. This makes it possible to announce the availability of a new drug without naming it directly – and thus to act within the framework of the Therapeutic Products Advertising Act. The app can provide patients with added value in the form of support and indication-specific knowledge transfer.

Missing real world data

As the number of people affected by an orphan disease is limited, clinical data is also only available to a limited extent. Health apps as added value for patients Beyond the Pill can continuously generate real-world data and collect patient feedback. The information can be incorporated into treatment optimization and post-market studies.

Get a picture of an exemplary business case at

Download

This is what an mHealth suite product for orphan drug needs could look like. Take a look at the example with the functionalit...

[borlabs-cookie id="hubspot-cb" type="content-blocker"][/borlabs-cookie]

What is conceivable is now also feasible

What should your mHealth Suite product look like?

Digitizing therapy concepts

Realize your product vision of innovative digital products Beyond the Pill as

  • Companion App
  • Therapy support (DTx)
  • Digital health application (DiGA)

*** Trade fair highlight of the DMEA 2024 ***

Your message to fluidmobile

Are you ready for the next generation of digital health apps?
Please feel free to contact us

[borlabs-cookie id="hubspot-cb" type="content-blocker"][/borlabs-cookie]

Karlsruhe

Bachstrasse 43